Keywords: آدفوویر دوپیفوکسیل; adefovir dipivoxil; bioequivalence; fixed-dosed combination; lamivudine; pharmacokinetics;
مقالات ISI آدفوویر دوپیفوکسیل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آدفوویر دوپیفوکسیل; Body composition; Multiple-frequency bioelectrical impedance; Hepatitis B; Adefovir dipivoxil; Entecavir
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: آدفوویر دوپیفوکسیل; AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
The nucleotide changes within HBV core promoter/precore during the first 12Â weeks of nucleos(t)ide treatment might be associated with a better virological response
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; BCP; basic core promoter; CHB; chronic hepatitis B; CP; core promoter; EN II; enhancer II; HBeAg; hepatitis e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; LMV; lamivudine; Mut; mutation; NUC; nucleoside/nuc
Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2
Keywords: آدفوویر دوپیفوکسیل; AA; amino acid; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HIV; human immunodeficiency virus; HSPGs; highly sulfated heparan sulfate proteoglycans; LdT; telb
Variability in long-term hepatitis B virus dynamics under antiviral therapy
Keywords: آدفوویر دوپیفوکسیل; CccDNA; Pegylated interferon alpha; Adefovir dipivoxil; Viral dynamics; Mathematical modelling
Adefovir dipivoxil — A possible regimen for the treatment of dengue virus (DENV) infection
Keywords: آدفوویر دوپیفوکسیل; Dengue serotype; Seropositive; Adefovir dipivoxil; Geo-coding; I-Tesser; Vaccine target; Molecular docking; In silico analysis
Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Hypophosphatemic osteomalacia; Clinical characteristic; SLC22A6; ABCC2; Risk genotype;
A novel baseline hepatitis B virus sequencing-based strategy for predicting adefovir antiviral response
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; AST; aspartic aminotransferase; AUC; area under the curve; BMI; body mass index; CHB; chronic hepatitis B; ETV; entecavir; HBV; hepatitis B virus; HCV; hepatitis C virus; HDV; hepatitis D virus; HCC;
Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversi
Keywords: آدفوویر دوپیفوکسیل; aa; amino acid; ADV; adefovir dipivoxil; anti-HBe; antibodies to hepatitis B e antigen; BCP; basic core promoter; C; core; CHB; chronic hepatitis B; CP; core promoter; Del/Ins; deletion/insertion; DR; direct repeat; EN; enhancer; S; surface; HBeAg; hepati
Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing
Keywords: آدفوویر دوپیفوکسیل; AD; adefovir dipivoxil; AhR; aryl hydrocarbon receptor; AMIO; amiodarone; APAP; acetaminophen; ATF4; activating transcription factor 4; CAA; chloroacetaldehyde; CdCl2; cadmium chloride; ChIP-seq; chromatin immunoprecipitation followed by DNA sequencing; C
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Keywords: آدفوویر دوپیفوکسیل; Chronic Delta Hepatitis; Pegylated Interferon Treatment; Treatment Outcome Prediction; On-Treatment HDV RNA; AD; adefovir dipivoxil; AUC; area under the curve; CDH; chronic delta hepatitis; CI; confidence interval; EOT; end of treatment; HBsAg; hepatitis
Molecular modeling and multispectroscopic studies of the interaction of hepatitis B drug, adefovir dipivoxil with human serum albumin
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Human serum albumin (HSA); Fluorescence quenching; Molecular docking; Hydrophobic interaction;
Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal
Keywords: آدفوویر دوپیفوکسیل; TDF; tenofovir disoproxil fumarate; HIV; human immunodeficiency virus; HBV; hepatitis B virus; CHB; chronic hepatitis B; ETV; entecavir; NUCs; nucleos(t)ides; LMV; lamivudine; ADV; adefovir dipivoxil; HCV; hepatitis C virus; ALT; alanine aminotransferase;
Entecavir 1Â mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study
Keywords: آدفوویر دوپیفوکسیل; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; ALT; alanine aminotransferase; AST; aspartate aminotransferase; NA; nucleos(t)ide analogues; LAM; lamivudine; ADV; adefovir dipivoxil; NHTMRI; National Hepatology and Tropica
Experimental and molecular docking studies on DNA binding interaction of adefovir dipivoxil: Advances toward treatment of hepatitis B virus infections
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; DNA interaction; Molecular docking; Groove binding
Recrystallization of adefovir dipivoxil particles using the rapid expansion of supercritical solutions (RESS) process
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Solubility; Supercritical CO2; RESS; Recrystallization;
Comparison of rescue strategies in lamivudine-resistant patients with chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; HBV; hepatitis B virus; LAM; lamivudine; ADV; adefovir dipivoxil; ETV; entecavir; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; ALT; alanine aminotransferase; Chronic hepatitis B; Lamivudine; Resistance; Adefovir dipivoxil; Entecavir;
Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients
Keywords: آدفوویر دوپیفوکسیل; adefovir dipivoxil; hepatitis B surface antigen; lamivudine resistance; nephrotoxicity; renal transplant recipient
Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; Meta-analysis; Lamivudine; Adefovir dipivoxil; Lamivudine-resistant; Chronic hepatitis B
Coformer selection based on degradation pathway of drugs: A case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Cocrystal; Saccharin; Nicotinamide; Degradation pathway;
ReviewHepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; CTP; Child-Turcotte-Pugh; ETV; entecavir; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HDV; hepatiti
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Keywords: آدفوویر دوپیفوکسیل; Prospective Clinical Trial; Replication Suppression; Liver Disease; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; EOT; end of treatment; NUC; nucleos(t)ide analogue; OR; odds ratio; PCR; polymerase chain reaction; SR; sustained response; ULN; upper l
Antiviral therapies: Focus on hepatitis B reverse transcriptase
Keywords: آدفوویر دوپیفوکسیل; HBV; Hepatitis B virus; HBsAg; HBV surface antigen; HBeAg; HBV e antigen; RT; reverse transcriptase; NRTI; nucleoside reverse transcriptase inhibitor; LVD/3TC; lamivudine; ADV; adefovir dipivoxil; ETV; entecavir; LdT; telbivudine; TDF; tenofovir disoproxi
Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells
Keywords: آدفوویر دوپیفوکسیل; P-glycoprotein (P-gp); Multidrug resistance-associated protein 4 (MRP4); Caco-2 cells; Adefovir dipivoxil; 1α,25-Dihydroxyvitamin D3 (1,25(OH)2D3); Vitamin D receptor (VDR)
Research ArticlePersistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; NUCs; nucleos(t)ide analogues; LAM; lamivudine; ADV; adefovir dipivoxil; ETV; entecavir; TBV; telbivudine; TDF; tenofovir disoproxil fumarate; HBV; hepatitis B virus; CHB; chronic hepatitis B; HIV; human immunodeficiency virus; WKPS; Wolters Kluwer Pharma
Research ArticleEvolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance
Keywords: آدفوویر دوپیفوکسیل; LAM; lamivudine; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; HCV; hepatitis C virus; HDV; hepatitis D virus; ALT; alanine amiontransferase; HBsAg; hepatitis B surface antigen; PCR; polymerase ch
Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; ALT; alanine aminotransferase activity; AST; aspartate aminotransferase activity; HBV; hepatitis B virus; HCV; hepatitis C virus; HDV; hepatitis D virus; LAM; lamivudine; pBS; pBluescript; WT; wild-type; Hepatitis B virus; Lamivud
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; ETV; entecavir; HBV; hepatitis B virus; LdT; telbivudine; LMV; lamivudine; NA; nucleos(t)ide analogs; TDF; tenofovir;
Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma
Keywords: آدفوویر دوپیفوکسیل; QRT-PCR; Friend leukemia virus; Adefovir dipivoxil; Entecavir; Plasma viral load;
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; ADV; adefovir dipivoxil; FTC; emtricitabine; HBeAg; hepatitis B e antigen; anti-HBe; hepatitis B e antibody; ALT; alanine aminotransaminase; PCR; polymerase chain reaction; HBV; hepatitis B virus; Combination therapy; Serum HBV DNA suppression; Normalizat
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; Anti-HBe; antibody to hepatitis B e-antigen; Anti-HBs; antibody to hepatitis B s-antigen; ALT; alanine aminotransferase; AT; as treated; CHB; chronic hepatitis B; DAVG; time-weighted average change from baseline; DNA; deoxyribonucleic acid; HBV; hepatitis
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Lamivudine-resistant mutant; Hepatitis B virus; rtA181T; rtN236T; Combination therapy; LAM; lamivudine; ADV; adefovir; rt; reverse transcriptase;
Entecavir
Keywords: آدفوویر دوپیفوکسیل; Entecavir; Hepatitis crónica por virus de la hepatitis B; Lamivudina; Adefovir dipivoxil; Supresión viral; Resistencias; Entecavir; Chronic hepatitis B; Lamivudine; Adefovir dipivoxil; Viral supresión; Resistance;
OriginalesPrograma de uso compasivo con adefovir dipivoxil en España: valoración de su eficacia y estudio de las resistenciasAdefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis
Keywords: آدفوویر دوپیفوکسیل; Hepatitis B crónica; Adefovir dipivoxil; Lamivudina; Resistencias; Tratamiento antivÃrico; Chronic hepatitis B; Adefovir dipivoxil; Lamividine; Resistance; Antiviral treatment;
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Lamivudine; Resistance; CHB; HBV
Profilaxis de reinfección por el virus de la hepatitis B postrasplante hepático
Keywords: آدفوویر دوپیفوکسیل; Hepatitis B; Trasplante hepático; Inmunoglobulinas hepatitis B; Lamivudina; Adefovir; Hepatitis B; Liver transplantation; Hepatitis B hyperimmune globulin; Lamivudine; Adefovir dipivoxil;
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1
Keywords: آدفوویر دوپیفوکسیل; Adefovir dipivoxil; Chronic hepatitis B; Human immunodeficiency virus; Lamivudine-resistance; Clinical trial